Molecular targeting of inosine-5’-monophosphate dehydrogenase by FF-10501 promotes erythropoiesis via ROS/MAPK pathway-Reference-Cited by-同舟云学术

Molecular targeting of inosine-5’-monophosphate dehydrogenase by FF-10501 promotes erythropoiesis via ROS/MAPK pathway

Published:2017-07-21 Issue:2 Volume:59 Page:448-459
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ichii Michiko¹,Oritani Kenji¹,Murase Motohiko²,Komatsu Kensuke²,Yamazaki Mao²,Kyoden Rie²,Kito Nobuko²,Nozaki Yusuke²,Saito Motoki²,Iwamura Hiroyuki³,Kanakura Yuzuru¹

Affiliation:

1. Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan;

2. Pharmaceutical & Healthcare Research Laboratories, Research & Development Management Headquarters, Pharmaceutical & Healthcare Research Laboratories, FUJIFILM Corporation, Kanagawa, Japan;

3. Pharmaceutical Products Division, FUJIFILM Corporation, Minato-ku, Tokyo, Japan

Funder

Fujifilm Corporation

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1339878

Reference36 articles.

1. Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics

2. Lack of cross‐resistance to FF‐10501, an inhibitor of inosine‐5′‐monophosphate dehydrogenase, in azacitidine‐resistant cell lines selected from SKM‐1 and MOLM‐13 leukemia cell lines

3. A Review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Folate depletion induces erythroid differentiation through perturbation of de novo purine synthesis;Science Advances;2024-02-02

2. Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets;Blood;2023-03-09

3. Folate depletion induces erythroid differentiation through perturbation of de novo purine synthesis;2022-12-22

4. Results of a Phase 1/2a dose–escalation study of FF-10501-01, an IMPDH inhibitor, in patients with acute myeloid leukemia or myelodysplastic syndromes;Leukemia & Lymphoma;2020-04-07

5. FF-10501 induces caspase-8-mediated apoptotic and endoplasmic reticulum stress-mediated necrotic cell death in hematological malignant cells;International Journal of Hematology;2019-08-12